In an early animal test, a new nasal-spray vaccine has shown promise against a variety of germs and a common allergen, ...

A vaccine usually trains your immune system to recognize one target. Here, the target is basically “anything that doesn’t ...

Stanford Medicine researchers have developed an intranasal liposomal vaccine that protected mice against SARS-CoV-2, ...

A new Stanford study marks a big step forward in the creation of a new kind of vaccine that offers protection against a range ...

An innovative approach supercharges the innate immune system to provide a first line of defence against respiratory ...

A new review by Dr. Ruyuan Wang and an international team of researchers explores the complex interactions between the innate and adaptive immune systems, shedding light on regulatory mechanisms in ...

Adaptive Biotechnologies (“we” or “our”) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment ...

Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into ...

In the realm of medical advancements, a universal vaccine that can protect against any pathogen has long been a Holy Grail—and about as elusive as a mythological vessel. But Stanford Medicine ...